BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasoha M, Bohle RM, Seibold A, Gerlinger C, Juhasz-Böss I, Solomayer EF. Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases. Clin Exp Metastasis 2018;35:763-75. [PMID: 30238177 DOI: 10.1007/s10585-018-9937-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Wood SL, Brown JE. Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases. Cancers (Basel) 2020;12:E2109. [PMID: 32751181 DOI: 10.3390/cancers12082109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
2 Kovalenko NV, Verenikina EV, Maksimov AY, Gladkikh ON, Demidova AA, Domashenko EV. Prediction of early recurrencies of uterine body cancer based on monitoring of serum biological markers. Klin Lab Diagn 2022;67:197-203. [PMID: 35575391 DOI: 10.51620/0869-2084-2022-67-4-197-203] [Reference Citation Analysis]
3 Chu HY, Chen Z, Wang L, Zhang ZK, Tan X, Liu S, Zhang BT, Lu A, Yu Y, Zhang G. Dickkopf-1: A Promising Target for Cancer Immunotherapy. Front Immunol 2021;12:658097. [PMID: 34093545 DOI: 10.3389/fimmu.2021.658097] [Reference Citation Analysis]
4 Li J, Gao Y, Yue W. The Clinical Diagnostic and Prognostic Value of Dickkopf-1 in Cancer. Cancer Manag Res 2020;12:4253-60. [PMID: 32606922 DOI: 10.2147/CMAR.S254596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Gao S, Jin Y, Zhang H. Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1). Front Genet 2021;12:757897. [PMID: 34899842 DOI: 10.3389/fgene.2021.757897] [Reference Citation Analysis]
6 El-Mahdy RI, Zakhary MM, Maximous DW, Mokhtar AA, El Dosoky MI. Circulating osteocyte-related biomarkers (vitamin D, sclerostin, dickkopf-1), hepcidin, and oxidative stress markers in early breast cancer: Their impact in disease progression and outcome. J Steroid Biochem Mol Biol 2020;204:105773. [PMID: 33065276 DOI: 10.1016/j.jsbmb.2020.105773] [Reference Citation Analysis]
7 Zhou X, Wang Y, Li Q, Ma D, Nie A, Shen X. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1). Biochem Biophys Res Commun 2020;530:47-53. [PMID: 32828314 DOI: 10.1016/j.bbrc.2020.06.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sun J, Chen X, Wang Y. Comparison of the diagnostic value of CEA combined with OPN or DKK1 in non-small cell lung cancer. Oncol Lett 2020;20:3046-52. [PMID: 32782622 DOI: 10.3892/ol.2020.11846] [Reference Citation Analysis]
9 Zhu G, Song J, Chen W, Yuan D, Wang W, Chen X, Liu H, Su H, Zhu J. Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients. Cancer Manag Res 2021;13:659-75. [PMID: 33536782 DOI: 10.2147/CMAR.S275172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kaplan Z, Zielske SP, Ibrahim KG, Cackowski FC. Wnt and β-Catenin Signaling in the Bone Metastasis of Prostate Cancer. Life (Basel) 2021;11:1099. [PMID: 34685470 DOI: 10.3390/life11101099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Meehan J, Gray M, Martínez-Pérez C, Kay C, Wills JC, Kunkler IH, Dixon JM, Turnbull AK. A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer. J Pers Med 2021;11:796. [PMID: 34442440 DOI: 10.3390/jpm11080796] [Reference Citation Analysis]
12 Wang M, Xia F, Wei Y, Wei X. Molecular mechanisms and clinical management of cancer bone metastasis. Bone Res 2020;8:30. [PMID: 34321455 DOI: 10.1038/s41413-020-00105-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
13 Lovero D, D'Oronzo S, Palmirotta R, Cafforio P, Brown J, Wood S, Porta C, Lauricella E, Coleman R, Silvestris F. Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases. Br J Cancer 2021. [PMID: 34272498 DOI: 10.1038/s41416-021-01481-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Paul MR, Pan TC, Pant DK, Shih NN, Chen Y, Harvey KL, Solomon A, Lieberman D, Morrissette JJ, Soucier-Ernst D, Goodman NG, Stavropoulos SW, Maxwell KN, Clark C, Belka GK, Feldman M, DeMichele A, Chodosh LA. Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets. J Clin Invest 2020;130:4252-65. [PMID: 32657779 DOI: 10.1172/JCI129941] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
15 Sareyeldin RM, Gupta I, Al-Hashimi I, Al-Thawadi HA, Al Farsi HF, Vranic S, Al Moustafa AE. Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer. Cancers (Basel) 2019;11:E646. [PMID: 31083383 DOI: 10.3390/cancers11050646] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]